Multicenter, Randomized Phase 2 Study Evaluating the Efficacy and Safety of HRS-5965 in Patients with Primary IgAN
用户6ZIx6grOXQAo
1个月前
102
10
已完结
1. 系统已在2026-05-28 16:38:14对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
文献链接: https://journals.lww.com/10.1681/ASN.202522jfb552
其他信息:
出版社: Ovid Technologies (Wolters Kluwer Health)
作者: Jicheng Lv; Yan Zha; Shuxin Liu; Dongwen Zheng; Rui Yan; Zengyan Li; Yinan Li; Sheng Qi; Yanfang Zou; Kaiyun Zhang; Chang Shu; Rong Huang; Liuchao Zhang; Hong Zhang

